Sign up to save your podcasts
Or
Share A New Treatment Paradigm for Diabetic Macular Edema
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
A New Treatment Paradigm for Diabetic Macular Edema
Dr. Jamie Dananberg, Chief Medical Officer of Unity Biotechnology discusses their strategy of selectively targeting senescent retinal vascular endothelial cells for a more long lasting effect on altering the pathophysiology of diabetic eye disease.
View all episodes
By Retina Synthesis
4.5
88 ratings
Dr. Jamie Dananberg, Chief Medical Officer of Unity Biotechnology discusses their strategy of selectively targeting senescent retinal vascular endothelial cells for a more long lasting effect on altering the pathophysiology of diabetic eye disease.
More shows like Retina Synthesis
View all
Ophthalmology off the Grid by Eyetube
43 Listeners
New Retina Radio by Eyetube
18 Listeners
Straight From The Cutter's Mouth: A Retina Podcast
99 Listeners
The Daily
113,179 Listeners
Up First from NPR
56,962 Listeners
JAMA Ophthalmology Author Interviews
5 Listeners
The Indicator from Planet Money
9,559 Listeners
The Retina Channel Podcast
12 Listeners
Dateline NBC
47,705 Listeners
Experts InSight
51 Listeners
RETINA Journal Podcasts
11 Listeners
Knock Knock, Hi! with the Glaucomfleckens
467 Listeners
Ophthalmology Journal
19 Listeners
ASRS’s Journal of Vitreoretinal Diseases (JVRD) Author’s Forum
0 Listeners